Resuscitative TEE Collaborative Registry

ConditionsCardiac Arrest Cardiac Arrest Circulatory Cardiac Arrest, Out-Of-Hospital Shock Hemodynamic Instability

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorUniversity of Pennsylvania

About this trial

The general objective of this study is to evaluate the clinical impact and safety of focused, point-of-care transesophageal echocardiography (TEE) used during the evaluation of critically-ill patients in the emergency and intensive care settings. The target population for this study are critically-ill patients over the age of 18 who as part of their routine clinical care are receiving a focused TEE.

The primary objective of this study is to determine the clinical impact and safety of TEE performed during the evaluation of critically-ill patients in the emergency department and intensive care settings.

The secondary objective(s) of this study are to characterize the use of this imaging modality in the subsets of critically-ill patients in shock and cardiac arrest; including but not limited to; description of the frequency of studies, clinical indications, clinician characteristics, echocardiography findings, timing of studies, procedure-related complications and patient outcomes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adult critically-ill patients who as part of their routine clinical care receive focused TEE in the emergency department of intensive care setting.

Disqualifiers

Children (age under 18 years)

Vulnerable populations

Trial population

Adult critically-ill patients who as part of their routine clinical care receive focused TEE in the emergency department of intensive care setting.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

1,000 Participants

are grouped into 5 trial groups

Group A: Out-of-hospital Cardiac Arrest

Group B: In-hospital Cardiac Arrest

Group C: Undifferentiated Shock or Acute Hemodynamic Decompensation

Group D: Hemodynamic Monitoring in a Critically Ill Patient

Group E: Procedural Guidance

Trial outcomes

Primary outcomes

The clinical impact and safety of TEE performed during the evaluation of critically ill patients in the emergency department and intensive care settings.

Determination of ROSC and survival to hospital discharge

Time frame

From the time of admission to the hospital until the date of discharge from the hospital or date of death from any cause, whichever occurs first, assessed up to 12 weeks

Secondary outcomes

The use of the TEE imaging modality in subsets of critically-ill patients in shock and cardiac arrest.

Description of the frequency of studies, clinical indications, clinician characteristics, echocardiography findings, timing of studies, procedure-related complications and patient outcomes.

Time frame

From the time of admission to the hospital until the date of discharge from the hospital or date of death from any cause, whichever occurs first, assessed up to 12 weeks

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Pennsylvania

Lead sponsor

Weill Medical College of Cornell University

Sponsor institution